Biotech AI (ex VantAI) che progetta farmaci a prossimità indotta, piccole molecole che avvicinano o separano proteine.
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Seed New York-based Proxima (formerly VantAI) emerged from stealth with an $80 million seed led by DCVC with Nvidia's NVentures for its 'molecular matchmaker' drugs. | $80M |